WSJ: 'Hydroxychloroquine and Azithromycin Continue to Show Results' for Coronavirus PatientsChris Menahan
Mar. 30, 2020
Cannon Hinnant, RIP: 5-Year-Old Boy 'Executed Point Blank' by Criminal Thug While Playing Outside
Latrell Allen: Meet The 20-Yr-Old Gangbanger Whose 'Shootout With Police' Triggered Mass Looting In Chicago
Reopening Gay Bathhouses Will Aid 'Economic And Cultural Recovery,' San Francisco Supervisor Says
Narrative Collapse: Media's Lies About George Floyd's Death Backfire After Video Leaked
Antifa End Up Getting Pummeled In A Ditch After Fight Breaks Out At 'Back The Blue' Rally In Colorado
Dr Jeff Colyer, the former governor of Kansas who is a practicing physician, reported Sunday in the Wall Street Journal that the combination of hydroxychloroquine and azithromycin is continuing to show "promising" results in coronavirus patients.
From The Wall Street Journal:
In the fight against Covid-19 though we might look forward in doom, one day we will look backward in awe. In an article last week, I discussed a promising drug combination to treat the disease. There is now new data supporting this treatment. Since then, Kansas City area physicians, including Joe Brewer, Dan Hinthorn and me, continue to treat many patients, and some have shown improvement. Major medical centers including the University of Washington and Mass General have added hydroxychloroquine to treatment options. [...]Here's an excerpt from French microbiologist Didier Raoult's second paper:
In 80 in-patients receiving a combination of hydroxychloroquine and azithromycin we noted a clinical improvement in all but one 86 year-old patient who died, and one 74 year- old patient still in intensive care unit.France 24 reports that "critics say such results were fairly typical of the virus":
Two Chinese studies have shown that "10 days after the start of symptoms, 90 percent of people who have a moderate form (of the disease) have a controlled viral load," epidemiologist Dominique Costagliola, of the French health research institute Inserm, told AFP.One Arizona man died and his wife was hospitalized last week after the two took excessive amounts and overdosed on chloroquine phosphate in fish tank cleaner form.
Several large-scale studies are currently being carried out in France and America to determine the drug's efficacy at both preventing and curing the virus.
In the meantime, the U.S. Department of Health & Human Services announced Sunday that "the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible."
Follow InformationLiberation on Twitter, Facebook, Gab and Minds.